Tenecteplase versus alteplase for thrombolysis in patients selected by use of perfusion imaging within 4·5 h of onset of ischaemic stroke (TASTE): a multicentre, randomised, controlled, phase 3 non-inf…

Overview of attention for article published in Lancet Neurology, June 2024

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (94th percentile)
Good Attention Score compared to outputs of the same age and source (77th percentile)

Mentioned by

news: 1 news outlet
twitter: 33 X users

reddit: 1 Redditor
guideline: 1 clinical guideline source

Readers on

mendeley: 61 Mendeley

So far, Altmetric has seen 38 X posts from 33 X users, with an upper bound of 116,589 followers.

TASTE trial + updated meta-analysis https://t.co/uS0zHTjaXa

Yes . Glad this issue is now done and dusted https://t.co/hNxwdi1Stc

Tenecteplase versus alteplase for thrombolysis in patients selected by use of perfusion imaging within 4·5 h of onset of ischaemic stroke (TASTE): A multicentre, randomised, controlled, phase 3 non-inferiority trial https://t.co/uNjVdyLdNy #whauthor #st…

RT @TheLancetNeuro: ICYMI: Results of the TASTE trial were published Online First, which is a randomised non-inferiority trial of tenectepl…

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 34 additional X posts.